BioSpace News Archive

DarioHealth Corp., a leader in the global digital therapeutics market, announced two new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022.

Memic Innovative Surgery Ltd. announced that HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration and The Women’s Hospital at Jackson Memorial have acquired the Hominis® Surgical System for use in single site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy.

Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers, announced the company will present at the upcoming 40th Annual J.P. Morgan Healthcare Conference, taking place virtually, Jan. 9 - 12.

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming virtual H.C. Wainwright BioConnect Conference, which runs from January 10 – 13, 2022.

ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded a contract with Leidos Biomedical Research, Inc., current operator of the Frederick National Laboratory for Cancer Research, for the continued production, characterization and distribution of next-generation cancer models.

Better Therapeutics, Inc. today provided an update on recent progress.

Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI ® (brexpiprazole) to Treat Schizophrenia in Pediatric Patients Ages 13-17.

Anokion SA today reported progress for its clinical-stage programs, KAN-101 and ANK-700.

VBL Therapeutics announced that Dror Harats, M.D., Chief Executive Officer of VBL Therapeutics, will present a corporate overview at the H.C. Wainwright BioConnect Virtual Conference being held on January 10 – 13, 2022.

Nexus Spine today announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing.